Latest Breaking News On - Novel drug discovery - Page 1 : comparemela.com

Lupin announces achievement of Key Milestone for its Phase 1 Clinical Stage MALT1 inhibitor Program

Lupin announces achievement of Key Milestone for its Phase 1 Clinical Stage MALT1 inhibitor Program
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Nilesh guptaAbbvie incLupin limitedKey milestoneManaging directorNovel drug discovery

Lupin : June 29, 2023 Lupin Announces Achievement of Key Milestone for its Phase 1 Clinical Stage MALT 1 inhibitor Program

Lupin s proprietary MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor is a protein involved in T-cell and B-cell lymphocyte activation Lupin has received additional .

South africaAsia pacificNilesh guptaAbbvie incLupin limitedBiotechnology pharmaceuticalsManaging directorNovel drug discoveryLatin americaMiddle eastGreat place

Lupin receives $25 million from AbbVie to initiate Phase 1 clinical trial for blood cancer treatment

Lupin receives $25 million from AbbVie to initiate Phase 1 clinical trial for blood cancer treatment
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.

Nilesh guptaAbbvie incLupin limitedManaging directorNovel drug discovery

Lupin gets $25 million from AbbVie for advancing cancer treatment research

Lupin gets $25 million from AbbVie for advancing cancer treatment research
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Nilesh guptaDrugmaker lupinLupin managing directorNovel drug discoveryLupin diagnostics

Lupin Announces Achievement Of Phase 1 Clinical Stage MALT1 Inhibitor Program

As part of the agreement, Lupin has received USD 25 million from AbbVie for initiation of Phase 1 clinical studies successfully.

Nilesh guptaAbbvie incLupin limited onLupin limitedManaging directorNovel drug discovery